News Center

位置：

Honors Announcement

Group News

Media Reports

Shisi Pharmaceutical Group Named “Best Small- and Mid-Cap Company”

Category:

Honors Announcement

发布时间：2022-12-20

【概要描述】 On December 19, the 7th Zhitong Finance Capital Markets Annual Conference and Golden Hong Kong Stocks Awards Ceremony, co-hosted by Zhitong Finance, China Galaxy Securities, and Tonghuashun Finance, was grandly held in Hangzhou. At the ceremony, Shisi Pharmaceutical Group was honored with the “Best Small- and Mid-Cap Company” award.

Shisi Pharmaceutical Group Named “Best Small- and Mid-Cap Company”

On December 19, the 7th Zhitong Finance Capital Markets Annual Conference and Golden Hong Kong Stocks Awards Ceremony, co-hosted by Zhitong Finance, China Galaxy Securities, and Tonghuashun Finance, was grandly held in Hangzhou. At the ceremony, Shisi Pharmaceutical Group was honored with the “Best Small- and Mid-Cap Company” award.

According to reports, the “Golden Hong Kong Stocks” event has now reached its seventh edition, emerging as the year’s premier Hong Kong stock gala and the world’s most authoritative platform for recognizing Hong Kong-listed companies. It serves as a leading indicator of the year’s most investment-worthy and growth-potential stocks, while also evolving into a major forum for the exchange of ideas among China’s business leaders, earning widespread acclaim from investors worldwide. The “Best Small- and Mid-Cap Company” award is designed to honor Hong Kong-listed firms in the small- and mid-cap segment whose business strategies align with growth expectations, demonstrate strong current operational performance, and exhibit significant growth potential.

As a major backbone enterprise in China’s pharmaceutical industry, Shisi Pharmaceutical Group has, in recent years, leveraged its core strengths and focused on the overarching theme of transformation, upgrading, quality improvement, and efficiency enhancement. Guided by innovation-driven development, the company has actively implemented a coordinated “four-wheel-drive” strategy encompassing generic drugs, active pharmaceutical ingredients, innovative drugs, and pharmaceutical packaging materials. By significantly increasing investment in R&D and drawing on high-level innovation platforms—such as its national-level Enterprise Technology Center and the National–Local Joint Engineering Laboratory that integrate industry, academia, research, and application—the Group has established a comprehensive, scientifically sound, and well-defined pathway for technological innovation and product development. It has continuously expanded its presence and intensified efforts in areas such as first-generic drugs, innovative medicines, specialty APIs, pharmaceutical packaging materials, and high-end complex formulations, thereby consistently empowering the company’s high-quality growth. Since the beginning of this year, Shisi Pharmaceutical Group has ranked among the top pharmaceutical companies nationwide in both the efficiency and volume of its specialty generic drug R&D, while also making significant progress in innovative drug research.

Meanwhile, Shisi Pharmaceutical Group has aligned its industrial chain with the innovation chain, leveraged the industrial chain to enhance the value chain, and accelerated the market development of new, iterative products that offer high added value and strong growth prospects. As a result, both domestic and international sales have maintained steady growth. In the first three quarters of this year, the Group’s revenue continued to expand at a robust pace, establishing itself as a key driver of innovation and development in China’s pharmaceutical industry and attracting widespread attention from the capital markets.

Keywords:

Shijiazhuang Sihua Pharmaceutical Recognized as a Provincial Model Enterprise for International Science and Technology Cooperation

Shijiazhuang Sihua Pharmaceutical Group’s Youyi Chemical has been recognized as a specialized, refined, distinctive, and innovative small and medium-sized enterprise in Hebei Province.

Shijiazhuang Sihua Pharmaceutical Recognized as a Provincial Model Enterprise for International Science and Technology Cooperation

Shijiazhuang Sihua Pharmaceutical Group’s Youyi Chemical has been recognized as a specialized, refined, distinctive, and innovative small and medium-sized enterprise in Hebei Province.